<p>SS&amp;H Financial Advisors Inc. 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第三季度将其在美敦力公司（Medtronic PLC，NYSE:MDT - 免费报告）的持股增加了 200.1%。该机构投资者在季度内购买了额外的 10,915 股后，持有该医疗技术公司 16,371 股股票。截至其最近向 SEC 提交的文件，SS&amp;H Financial Advisors Inc. 在美敦力的持股价值为 1,559,000 美元。</p>
<ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也增加或减少了在该公司的股份。1248 Management LLC 在第一季度以约 26,000 美元的价格获得了美敦力的新股份。Delos Wealth Advisors LLC 在第二季度以约 27,000 美元的价格购买了美敦力的新股份。Twin Tree Management LP 在第一季度以约 29,000 美元的价格购买了美敦力的新股份。Activest Wealth Management 在第一季度将其在美敦力的持股增加了 3,577.8%。Activest Wealth Management 目前持有 331 股该医疗技术公司的股票，价值 30,000 美元，此前在上个季度又购买了 322 股。最后，GFG Capital LLC 在第二季度以约 36,000 美元的价格购买了美敦力的新股份。对冲基金和其他机构投资者持有该公司 82.06% 的股票。</p>
<h2>美敦力股票表现</h2>
<p>美敦力（MDT）股票周一开盘价为 96.52 美元。该公司的市值为 1,237.4 亿美元，市盈率为 26.02，PEG 比率为 2.54，贝塔值为 0.71。美敦力 PLC 的 1 年最低价为 79.29 美元，1 年最高价为 106.33 美元。该股票的 50 日移动平均线为 97.54 美元，200 日移动平均线为 93.80 美元。该公司的债务与股本比率为 0.57，速动比率为 1.80，流动比率为 2.42。</p>
<ul>
<li>MarketBeat 周报 – 08/18 - 08/22</li>
</ul>
<p>美敦力（NYSE:MDT - 获取免费报告）最近在 11 月 18 日（星期二）公布了其财报。该医疗技术公司报告本季度每股收益为 1.36 美元，超出分析师一致预期的 1.31 美元，超出幅度为 0.05 美元。美敦力的净利润率为 13.71%，股本回报率为 14.86%。该公司本季度的收入为 89.6 亿美元，而分析师预期为 88.6 亿美元。与去年同期相比，该公司每股收益为 1.26 美元，收入增长了 6.6%。美敦力已将其 2026 财年的指导目标设定为每股收益 5.620-5.660 美元。分析师预测美敦力 PLC 本年度每股收益将为 5.46 美元。</p>
<h2>美敦力宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 1 月 16 日（星期五）支付。12 月 26 日（星期五）的股东将获得 0.71 美元的分红。除息日为 12 月 26 日（星期五）。这代表着年化分红为 2.84 美元，分红收益率为 2.9%。美敦力的分红支付比率（DPR）目前为 76.55%。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
<p>一些股票研究分析师最近对该公司发布了报告。Weiss Ratings 在 12 月 15 日（星期一）的研究报告中重申了对美敦力股票的 “买入（b）” 评级。Piper Sandler 在 11 月 14 日（星期五）的报告中重申了对美敦力股票的 “中性” 评级。摩根士丹利在 11 月 19 日（星期三）的报告中将美敦力股票的目标价从 107.00 美元上调至 117.00 美元，并给予该公司 “增持” 评级。巴克莱在 11 月 20 日（星期四）的研究报告中将美敦力股票的目标价从 109.00 美元上调至 111.00 美元，并给予该股票 “增持” 评级。最后，Truist Financial 在 12 月 18 日（星期四）的报告中将美敦力股票的目标价从 110.00 美元下调至 107.00 美元，并对该公司设定了 “持有” 评级。一位股票研究分析师对该股票给予了强烈买入评级，十三位给予了买入评级，十二位对该公司给予了持有评级。根据 MarketBeat，该公司目前的共识评级为 “适度买入”，共识目标价为 109.94 美元。</p>
<p><strong>查看我们最新的美敦力股票分析</strong></p>
<h2>美敦力公司简介</h2>
<p>（免费报告）</p>
<p>美敦力公司是一家全球医疗技术公司，开发和制造广泛的治疗设备和医疗保健解决方案。公司合法注册于爱尔兰，主要运营办公室位于美国，向全球医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
<p>美敦力的产品涵盖多个临床领域，包括心脏节律和心力衰竭（起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统和外科创新）、恢复性治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
<h2>阅读更多</h2>
<ul>
<li>我们更看好的五只股票超过美敦力</li>
<li>请勿删除，立即阅读</li>
<li>富人如何退休</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>100 万美元在退休中能维持多久？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经确定了五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>SS&H Financial Advisors Inc. 在第三季度将其在美敦力（Medtronic PLC，NYSE:MDT）的持股增加了 200.1%，目前持有 16,371 股，市值为 1,559,000 美元。其他机构投资者也调整了他们的持仓。美敦力的股票开盘价为 96.52 美元，市值为 1,237.4 亿美元。该公司报告第三季度每股收益为 1.36 美元，超出预期，并宣布季度股息为 0.71 美元。分析师对该公司的共识评级为 “适度买入”，目标价为 109.94 美元</p>

<p>SS&amp;H Financial Advisors Inc. increased its position in shares of Medtronic PLC (NYSE:MDT - Free Report) by 200.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,371 shares of the medical technology company's stock after purchasing an additional 10,915 shares during the quarter. SS&amp;H Financial Advisors Inc.'s holdings in Medtronic were worth $1,559,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>SS&amp;H Financial Advisors Inc. 在最近向美国证券交易委员会（SEC）披露的信息中表示，在第三季度将其在美敦力公司（Medtronic PLC，NYSE:MDT - 免费报告）的持股增加了 200.1%。该机构投资者在季度内购买了额外的 10,915 股后，持有该医疗技术公司 16,371 股股票。截至其最近向 SEC 提交的文件，SS&amp;H Financial Advisors Inc. 在美敦力的持股价值为 1,559,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. 1248 Management LLC acquired a new stake in shares of Medtronic in the first quarter valued at about $26,000. Delos Wealth Advisors LLC purchased a new stake in Medtronic during the 2nd quarter valued at about $27,000. Twin Tree Management LP purchased a new stake in Medtronic during the 1st quarter valued at about $29,000. Activest Wealth Management raised its holdings in Medtronic by 3,577.8% in the 1st quarter. Activest Wealth Management now owns 331 shares of the medical technology company's stock valued at $30,000 after acquiring an additional 322 shares during the last quarter. Finally, GFG Capital LLC purchased a new position in Medtronic in the 2nd quarter worth approximately $36,000. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也增加或减少了在该公司的股份。1248 Management LLC 在第一季度以约 26,000 美元的价格获得了美敦力的新股份。Delos Wealth Advisors LLC 在第二季度以约 27,000 美元的价格购买了美敦力的新股份。Twin Tree Management LP 在第一季度以约 29,000 美元的价格购买了美敦力的新股份。Activest Wealth Management 在第一季度将其在美敦力的持股增加了 3,577.8%。Activest Wealth Management 目前持有 331 股该医疗技术公司的股票，价值 30,000 美元，此前在上个季度又购买了 322 股。最后，GFG Capital LLC 在第二季度以约 36,000 美元的价格购买了美敦力的新股份。对冲基金和其他机构投资者持有该公司 82.06% 的股票。</p>
</div><h2>Medtronic Stock Performance</h2>
<div class="lb-trans"><h2>美敦力股票表现</h2>
</div><p>Shares of MDT stock opened at $96.52 on Monday. The firm has a market cap of $123.74 billion, a price-to-earnings ratio of 26.02, a PEG ratio of 2.54 and a beta of 0.71. Medtronic PLC has a 1 year low of $79.29 and a 1 year high of $106.33. The stock's 50-day moving average is $97.54 and its two-hundred day moving average is $93.80. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.80 and a current ratio of 2.42.</p>
<div class="lb-trans"><p>美敦力（MDT）股票周一开盘价为 96.52 美元。该公司的市值为 1,237.4 亿美元，市盈率为 26.02，PEG 比率为 2.54，贝塔值为 0.71。美敦力 PLC 的 1 年最低价为 79.29 美元，1 年最高价为 106.33 美元。该股票的 50 日移动平均线为 97.54 美元，200 日移动平均线为 93.80 美元。该公司的债务与股本比率为 0.57，速动比率为 1.80，流动比率为 2.42。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 08/18 - 08/22</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last announced its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating analysts' consensus estimates of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The business had revenue of $8.96 billion during the quarter, compared to analysts' expectations of $8.86 billion. During the same period in the prior year, the company earned $1.26 earnings per share. The business's revenue was up 6.6% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Analysts predict that Medtronic PLC will post 5.46 earnings per share for the current year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 获取免费报告）最近在 11 月 18 日（星期二）公布了其财报。该医疗技术公司报告本季度每股收益为 1.36 美元，超出分析师一致预期的 1.31 美元，超出幅度为 0.05 美元。美敦力的净利润率为 13.71%，股本回报率为 14.86%。该公司本季度的收入为 89.6 亿美元，而分析师预期为 88.6 亿美元。与去年同期相比，该公司每股收益为 1.26 美元，收入增长了 6.6%。美敦力已将其 2026 财年的指导目标设定为每股收益 5.620-5.660 美元。分析师预测美敦力 PLC 本年度每股收益将为 5.46 美元。</p>
</div><h2>Medtronic Announces Dividend</h2>
<div class="lb-trans"><h2>美敦力宣布分红</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Friday, January 16th. Stockholders of record on Friday, December 26th will be given a $0.71 dividend. The ex-dividend date is Friday, December 26th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 2.9%. Medtronic's dividend payout ratio (DPR) is currently 76.55%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 1 月 16 日（星期五）支付。12 月 26 日（星期五）的股东将获得 0.71 美元的分红。除息日为 12 月 26 日（星期五）。这代表着年化分红为 2.84 美元，分红收益率为 2.9%。美敦力的分红支付比率（DPR）目前为 76.55%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
</div><p>A number of equities research analysts have recently issued reports on the company. Weiss Ratings restated a &#34;buy (b)&#34; rating on shares of Medtronic in a research report on Monday, December 15th. Piper Sandler reiterated a &#34;neutral&#34; rating on shares of Medtronic in a report on Friday, November 14th. Morgan Stanley boosted their price objective on shares of Medtronic from $107.00 to $117.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, November 19th. Barclays increased their target price on shares of Medtronic from $109.00 to $111.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, November 20th. Finally, Truist Financial dropped their target price on shares of Medtronic from $110.00 to $107.00 and set a &#34;hold&#34; rating for the company in a report on Thursday, December 18th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $109.94.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对该公司发布了报告。Weiss Ratings 在 12 月 15 日（星期一）的研究报告中重申了对美敦力股票的 “买入（b）” 评级。Piper Sandler 在 11 月 14 日（星期五）的报告中重申了对美敦力股票的 “中性” 评级。摩根士丹利在 11 月 19 日（星期三）的报告中将美敦力股票的目标价从 107.00 美元上调至 117.00 美元，并给予该公司 “增持” 评级。巴克莱在 11 月 20 日（星期四）的研究报告中将美敦力股票的目标价从 109.00 美元上调至 111.00 美元，并给予该股票 “增持” 评级。最后，Truist Financial 在 12 月 18 日（星期四）的报告中将美敦力股票的目标价从 110.00 美元下调至 107.00 美元，并对该公司设定了 “持有” 评级。一位股票研究分析师对该股票给予了强烈买入评级，十三位给予了买入评级，十二位对该公司给予了持有评级。根据 MarketBeat，该公司目前的共识评级为 “适度买入”，共识目标价为 109.94 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on MDT</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的美敦力股票分析</strong></p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>美敦力公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.</p>
<div class="lb-trans"><p>美敦力公司是一家全球医疗技术公司，开发和制造广泛的治疗设备和医疗保健解决方案。公司合法注册于爱尔兰，主要运营办公室位于美国，向全球医院、医生和医疗系统销售产品，自 1949 年成立以来，已发展成为服务全球医疗市场的最大医疗设备制造商之一。</p>
</div><p>Medtronic's offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).</p>
<div class="lb-trans"><p>美敦力的产品涵盖多个临床领域，包括心脏节律和心力衰竭（起搏器、植入式心脏复律除颤器及相关心脏治疗）、微创和外科技术（腹腔镜和先进能量设备、可视化系统和外科创新）、恢复性治疗（脊柱和骨科、神经调节和神经血管治疗）以及糖尿病管理（胰岛素输送系统和血糖监测解决方案）。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Do not delete, read immediately</li>
<li>How the Rich Retire</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>How Long Will $1M Last in Retirement?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过美敦力</li>
<li>请勿删除，立即阅读</li>
<li>富人如何退休</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>100 万美元在退休中能维持多久？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经确定了五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

SS&H Financial Advisors Inc. 购买了美敦力公司 $MDT 的股票